Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.
Tseng YH, Tran TTM, Tsai Chang J, Huang YT, Nguyen AT, Chang IY, Chen YT, Hsieh HW, Juang YL, Chang PM, Huang TY, Chang YC, Chen YM, Liu H, Huang CF.
Tseng YH, et al. Among authors: chen yt.
Cell Death Discov. 2025 Jan 27;11(1):26. doi: 10.1038/s41420-025-02300-7.
Cell Death Discov. 2025.
PMID: 39870629
Free article.